| Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and healthcare professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Hait William | See Remarks | Apr 21 | Option Exercise | 90.44 | 29,699 | 2,685,978 | 109,935 | Apr 25 04:33 PM | | Hait William | See Remarks | Apr 21 | Sale | 183.58 | 29,699 | 5,452,053 | 80,236 | Apr 25 04:33 PM | | Mongon Thibaut | Exec VP, WW Chair, Consumer | Mar 17 | Option Exercise | 100.69 | 30,785 | 3,099,895 | 74,688 | Mar 21 04:38 PM | | Mongon Thibaut | Exec VP, WW Chair, Consumer | Mar 17 | Sale | 176.26 | 10,874 | 1,916,671 | 63,814 | Mar 21 04:38 PM | | Mongon Thibaut | Exec VP, WW Chair, Consumer | Mar 17 | Sale | 176.25 | 23,681 | 4,173,718 | 40,133 | Mar 21 04:38 PM | | Decker Robert J | Controller, CAO | Mar 15 | Option Exercise | 72.54 | 5,000 | 362,700 | 20,473 | Mar 17 04:30 PM | | Decker Robert J | Controller, CAO | Mar 15 | Sale | 175.51 | 5,000 | 877,530 | 15,473 | Mar 17 04:30 PM | | Mammen Mathai | EVP, Pharm, R&D | Feb 15 | Option Exercise | 0.00 | 7,740 | 0 | 45,300 | Feb 17 06:00 AM | | Wengel Kathryn E | EVP, Chief GSC Officer | Feb 15 | Option Exercise | 0.00 | 10,386 | 0 | 76,010 | Feb 17 06:01 AM | | Duato Joaquin | CEO | Feb 15 | Option Exercise | 0.00 | 29,714 | 0 | 258,879 | Feb 17 06:00 AM | | Gorsky Alex | Director | Feb 15 | Option Exercise | 0.00 | 60,965 | 0 | 611,919 | Feb 17 06:00 AM | | McEvoy Ashley | EVP, WW Chair, Medical Devices | Feb 15 | Option Exercise | 0.00 | 15,806 | 0 | 48,055 | Feb 17 06:01 AM | | Wolk Joseph J | Exec VP, CFO | Feb 15 | Option Exercise | 0.00 | 17,793 | 0 | 43,177 | Feb 17 06:01 AM | | Mongon Thibaut | Exec VP, WW Chair, Consumer | Feb 15 | Option Exercise | 0.00 | 3,922 | 0 | 45,746 | Feb 17 06:01 AM | | Decker Robert J | Controller, CAO | Feb 15 | Option Exercise | 0.00 | 903 | 0 | 15,721 | Feb 17 06:01 AM | | Ullmann Michael H | Exec VP, General Counsel | Feb 15 | Option Exercise | 0.00 | 13,186 | 0 | 165,044 | Feb 17 06:00 AM | | Broadhurst Vanessa | EVP, Global Corp Aff. | Feb 15 | Option Exercise | 0.00 | 2,557 | 0 | 16,592 | Feb 17 06:00 AM | | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 15 | Option Exercise | 0.00 | 18,064 | 0 | 135,297 | Feb 17 06:01 AM | | Hait William | See Remarks | Feb 15 | Option Exercise | 0.00 | 8,128 | 0 | 84,394 | Feb 18 07:15 PM | | Wolk Joseph J | Exec VP, CFO | Feb 14 | Option Exercise | 0.00 | 3,248 | 0 | 26,305 | Feb 15 08:04 PM | | Hait William | See Remarks | Feb 14 | Option Exercise | 0.00 | 7,790 | 0 | 230,948 | Feb 15 08:04 PM | | Duato Joaquin | CEO | Feb 14 | Option Exercise | 0.00 | 5,424 | 0 | 231,521 | Feb 15 08:04 PM | | Gorsky Alex | Director | Feb 14 | Option Exercise | 0.00 | 11,129 | 0 | 555,787 | Feb 15 08:04 PM | | Decker Robert J | Controller, CAO | Feb 14 | Option Exercise | 0.00 | 866 | 0 | 15,081 | Feb 15 08:02 PM | | McEvoy Ashley | EVP, WW Chair, Medical Devices | Feb 14 | Option Exercise | 0.00 | 2,885 | 0 | 33,041 | Feb 15 08:03 PM | | Mongon Thibaut | Exec VP, WW Chair, Consumer | Feb 14 | Option Exercise | 0.00 | 3,759 | 0 | 43,344 | Feb 15 08:03 PM | | Ullmann Michael H | Exec VP, General Counsel | Feb 14 | Option Exercise | 0.00 | 2,407 | 0 | 152,729 | Feb 15 08:03 PM | | Broadhurst Vanessa | EVP, Global Corp Aff. | Feb 14 | Option Exercise | 0.00 | 2,451 | 0 | 14,937 | Feb 15 08:03 PM | | Wengel Kathryn E | EVP, Chief GSC Officer | Feb 14 | Option Exercise | 0.00 | 1,896 | 0 | 66,319 | Feb 15 08:03 PM | | Mammen Mathai | EVP, Pharm, R&D | Feb 14 | Option Exercise | 0.00 | 7,418 | 0 | 39,895 | Feb 15 08:03 PM | | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 14 | Option Exercise | 0.00 | 3,297 | 0 | 118,423 | Feb 15 08:02 PM | | Fasolo Peter | Exec VP, Chief HR Officer | Feb 14 | Option Exercise | 0.00 | 2,036 | 0 | 109,379 | Feb 15 08:02 PM | | Fasolo Peter | Exec VP, Chief HR Officer | Feb 14 | Option Exercise | 0.00 | 11,154 | 0 | 118,497 | Feb 17 06:00 AM | | Duato Joaquin | CEO | Jan 14 | Option Exercise | 65.37 | 84,423 | 5,518,732 | 280,475 | Jan 19 08:54 PM | | Gorsky Alex | Director | Jan 14 | Option Exercise | 65.37 | 231,951 | 15,162,637 | 695,601 | Jan 19 08:54 PM | | Decker Robert J | Controller, CAO | Dec 07 | Option Exercise | 72.54 | 5,000 | 362,700 | 19,215 | Dec 09 04:43 PM | | Decker Robert J | Controller, CAO | Dec 07 | Sale | 163.21 | 5,000 | 816,050 | 14,215 | Dec 09 04:43 PM |
|
